AKT1 and lung cancer: SYUNZ-16 inhibits AKT signaling pathway, and down-regulates the phosphorylation of AKT in a dose and time-dependent manner, subsequently initiating apoptotic events in Hep3B liver cancer and GLC-82 lung cancer cells (Deng et al., 2010).